Home/Filings/4/0001144204-16-138849
4//SEC Filing

China Biologic Products, Inc. 4

Accession 0001144204-16-138849

CIK 0001369868operating

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 6:50 AM ET

Size

11.6 KB

Accession

0001144204-16-138849

Insider Transaction Report

Form 4
Period: 2016-12-09
Yeung Albert
Director
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2016-12-0920,0000 total
    Exercise: $10.57From: 2013-07-30Exp: 2022-07-29Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2016-12-09$9.85/sh+5,000$49,25045,000 total
  • Exercise/Conversion

    Common Stock

    2016-12-09$10.57/sh+20,000$211,40040,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2016-12-095,0000 total
    Exercise: $9.85From: 2013-09-01Exp: 2022-08-31Common Stock (5,000 underlying)
Footnotes (3)
  • [F1]Acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnotes 2 and 3 below for further details on the relevant stock options.
  • [F2]Represents previously reported ten-year non-qualified stock options to purchase 20,000 shares of the Issuer's common stock granted to the Reporting Person under the Issuer's 2008 equity incentive plan pursuant to a stock option agreement dated July 29, 2012 and vested in two equal tranches on January 30, 2013 and July 30, 2013.
  • [F3]Represents previously reported ten-year non-qualified stock options to purchase 5,000 shares of the Issuer's common stock granted to the Reporting Person under the Issuer's 2008 equity incentive plan pursuant to a stock option agreement dated August 31, 2012 and vested on September 1, 2013.

Issuer

China Biologic Products, Inc.

CIK 0001369868

Entity typeoperating

Related Parties

1
  • filerCIK 0001369868

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:50 AM ET
Size
11.6 KB